glutathione and breast cancer treatment Glutathione-mediated nanomedicines for diagnosis therapy What do cancer cells eat?

Kumbhar et al., 2022

Perron U, Grassi E, Chatzipli A, Viviani M, Karakoc E, Trastulla L, et al

A peptide that survives one accidental overnight exposure at 70% of its original potency becomes 49% effective after a second identical exposure (0.70 0.70 = 0.49)

Exact flavan-3,3,4-triol ( 4 ) concentration was evaluated by a full conversion control reaction containing 5 M Pt GSTF8 in the second step and quantification of the product cyanidin ( 8 ) by HPLCMS

Despite these numbers, humans may not be producing enough of this

Both peptides show published activity across rodent and cell-culture tissue-repair models without binding a single canonical receptor, distinguishing the blend from receptor-targeted compounds